CoChat

Rheological, Structural, and Biological Trade-Offs in Bioink Design for 3D Bioprinting

Open access
Elango, Jeevithan, Zamora-Ledezma, Camilo · 2025 · Gels

The DOI matches its Crossref record; 121 of the 121 references it cites were found in a registry or an index.

Abstract

Bioinks represent the core of 3D bioprinting, as they are the carrier responsible for enabling the fabrication of anatomically precise, cell-laden constructs that replicate native tissue architecture. Indeed, their role goes beyond structural support, as they must also sustain cellular viability, proliferation, and differentiation functions, which are critical for applications in the field of regenerative medicine and personalized therapies. However, at present, a persistent challenge lies in reconciling the conflicting demands of rheological properties, which are essential for printability and biological functionality. This trade-off limits the clinical translation of bioprinted tissues, particularly for vascularized or mechanically dynamic organs. Despite huge progress during the last decade, challenges persist in standardizing bioink characterization, scaling production, and ensuring long-term biomimetic performance. Based on these challenges, this review explores the inherent trade-off faced by bioink research optimizing rheology to ensure printability, shape fidelity, and structural integrity, while simultaneously maintaining high cell viability, proliferation, and tissue maturation offering insights into designing next-generation bioinks for functional tissue engineering.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/gels11080659

Cites

121 of 121 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Overall concept of Rheological Properties and Future Directions in Bioprinting Technologies.
Figure 1 Overall concept of Rheological Properties and Future Directions in Bioprinting Technologies.CC BY · PubMed Central
Figure 2 Schematization of the interlink between printability & biological functionality in cell-laden bioprinted scaffolds and organs.
Figure 2 Schematization of the interlink between printability & biological functionality in cell-laden bioprinted scaffolds and organs.CC BY · PubMed Central
Figure 3 (A) Anti-oxidative bioinks (methacrylate-modified rutin-glycidyl methacrylate silk fibroin) for cartilage tissue engineering application [86]. (B) Visualization of cartilage with C28/I2 chondrocytes on decellularized scaffold by scanning electron microscopy. Cells attached to scaffold after 1 week in culture. (Scale bar = 20 µm) [105]. (C) Biocompatibility (i) Cell viability by Live/dead cell staining,(scale bars = 200 µm)) and (ii) chondrogenic inductivity of methacrylated cartilage extracellular matrix constructs stained for type I and II collagens and sGAGs (scale bars = 100 µm) [106]. Adapted under open access Creative Commons CCBY 4.0 license/ through open access permission from Refs. [86,105,106].
Figure 3 (A) Anti-oxidative bioinks (methacrylate-modified rutin-glycidyl methacrylate silk fibroin) for cartilage tissue engineering application [86]. (B) Visualization of cartilage with C28/I2 chondrocytes on decellularized scaffold by scanning electron microscopy. Cells attached to scaffold after 1 week in culture. (Scale bar = 20 µm) [105]. (C) Biocompatibility (i) Cell viability by Live/dead cell staining,(scale bars = 200 µm)) and (ii) chondrogenic inductivity of methacrylated cartilage extracellular matrix constructs stained for type I and II collagens and sGAGs (scale bars = 100 µm) [106]. Adapted under open access Creative Commons CCBY 4.0 license/ through open access permission from Refs. [86,105,106].CC BY · PubMed Central
Figure 4 (A) Omentum decellularization and ECM hydrogel generation. (i)—Native omentum, (ii)—De cellularized omentum, (iii)—Representative hrSEM image of the hydrogel. Scale bar = 1 µm. (B) (i)—YIGSR-alginate gel generation schematics and (ii)—Adhesion of iPSCs-derived ECs to pristine (left) and modified alginate (right) sheets, 4 h post-seeding. (scale bar = 100 μm) (C) The 3D printed vascularized patches. (i) The bioinks that were used in the printing process. (ii) Schematics of the patch bioprinting process. (iii) Viability after printing. (iv) Representative fluorescence image of two printed large blood vessels stained for F-actin and DAPI after 14 days in culture (scale bar = 100 μm). (v) Representative fluorescence image of a printed large blood vessel and surrounding capillary-like structures stained for F-actin and DAPI after 14 days in culture (scale bar = 100 μm). (vi) Representative 3D confocal images of a 3D printed blood vessel immunostained for the endothelial cell marker CD31 after 14 days in culture, EC monolayer zoom-in image (top), a zoom-in image showing EC sprouting from the blood vessel wall (bottom) (scale bars = 100 μm). (vii) Representative 3D confocal images of a 3D printed blood vessel immunostained for CD31 after 14 days in culture (scale bar = 100 μm) [64]. Adapted under open access Creative Commons CCBY 4.0 license/through open access permission from Ref. [64].
Figure 4 (A) Omentum decellularization and ECM hydrogel generation. (i)—Native omentum, (ii)—De cellularized omentum, (iii)—Representative hrSEM image of the hydrogel. Scale bar = 1 µm. (B) (i)—YIGSR-alginate gel generation schematics and (ii)—Adhesion of iPSCs-derived ECs to pristine (left) and modified alginate (right) sheets, 4 h post-seeding. (scale bar = 100 μm) (C) The 3D printed vascularized patches. (i) The bioinks that were used in the printing process. (ii) Schematics of the patch bioprinting process. (iii) Viability after printing. (iv) Representative fluorescence image of two printed large blood vessels stained for F-actin and DAPI after 14 days in culture (scale bar = 100 μm). (v) Representative fluorescence image of a printed large blood vessel and surrounding capillary-like structures stained for F-actin and DAPI after 14 days in culture (scale bar = 100 μm). (vi) Representative 3D confocal images of a 3D printed blood vessel immunostained for the endothelial cell marker CD31 after 14 days in culture, EC monolayer zoom-in image (top), a zoom-in image showing EC sprouting from the blood vessel wall (bottom) (scale bars = 100 μm). (vii) Representative 3D confocal images of a 3D printed blood vessel immunostained for CD31 after 14 days in culture (scale bar = 100 μm) [64]. Adapted under open access Creative Commons CCBY 4.0 license/through open access permission from Ref. [64].CC BY · PubMed Central
Figure 5 (A) 3D printed PLA-45S5 BG scaffolds. (i)—CAD render of PLA-BG scaffolds with a pore size of width = 750 μm, (ii)—FDM 3D printed PLA-BG scaffolds (PLA-0%, PLA-1%, PLA-2.5%, PLA-5%, and PLA-10%), Scale bars: 500 μm, (iii)—Top view light microscopy image of a PLA-BG scaffold. Scale bar: 2 mm. (iv–vii): Printability assessment and porosity analysis of PLA-BG scaffolds. ** p < 0.01, **** p < 0.0001 indicate statistical significant difference of means in comparison to 3D printed 0% BG PLA by one-way ANOVA or Welch’s t-test in pairwise comparisons of scaffold side pore diameter. (B) Mechanical properties of 3D printed PLA-45S5 BG scaffolds, (i)—Macroscopic images illustrating different failure modes of 1 and 10% (wt), (ii)—Qualitative stress strain diagram, (iii)—Compression strength and modulus of elasticity of 3D printed PLA-BG scaffolds. (C) Fluorescence microscopy images of Calcein AM (green)/DAPI (blue) stained MC3T3E1 on 3D printed PLA-BG scaffolds (Scale bar: 200 μm). Adapted under open access Creative Commons CCBY 4.0 license/through open access permission from Ref. [116].
Figure 5 (A) 3D printed PLA-45S5 BG scaffolds. (i)—CAD render of PLA-BG scaffolds with a pore size of width = 750 μm, (ii)—FDM 3D printed PLA-BG scaffolds (PLA-0%, PLA-1%, PLA-2.5%, PLA-5%, and PLA-10%), Scale bars: 500 μm, (iii)—Top view light microscopy image of a PLA-BG scaffold. Scale bar: 2 mm. (iv–vii): Printability assessment and porosity analysis of PLA-BG scaffolds. ** p < 0.01, **** p < 0.0001 indicate statistical significant difference of means in comparison to 3D printed 0% BG PLA by one-way ANOVA or Welch’s t-test in pairwise comparisons of scaffold side pore diameter. (B) Mechanical properties of 3D printed PLA-45S5 BG scaffolds, (i)—Macroscopic images illustrating different failure modes of 1 and 10% (wt), (ii)—Qualitative stress strain diagram, (iii)—Compression strength and modulus of elasticity of 3D printed PLA-BG scaffolds. (C) Fluorescence microscopy images of Calcein AM (green)/DAPI (blue) stained MC3T3E1 on 3D printed PLA-BG scaffolds (Scale bar: 200 μm). Adapted under open access Creative Commons CCBY 4.0 license/through open access permission from Ref. [116].CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 121 references

Research works printed but not linked: 1

  1. (2025, April 25). GlobeNewswire FluidForm Bio Announces Advance in Bioprinted Tissue Therapies with Landmark Publication in Science Advances. Available online: https://www.biospace.com/press-releases/fluidform-bio-announces-advance-in-bioprinted-tissue-therapies-with-landmark-publication-in-science-advances.

Cited by

See all 75

Metadata

Authors
Elango, J., & Zamora-Ledezma, C.
Affiliations
  • Universidad Católica de Murcia (ES)
  • Bioengineering & Regenerative Medicine Research Group (Bio-ReM), Escuela de Ingeniería, Arquitectura y Diseño (EIAD), Universidad Alfonso X el Sabio (UAX), Avenida de la Universidad 1, Villanueva de la Cañada, 28691 Madrid, Spain
Corresponding author
Elango, Jeevithan
Venue
Gels
Publisher
MDPI AG
Published
2025-08-19
Volume
11
Issue
8
Pages
659
ISSN
2310-2861 (ISSN-L)
OpenAlex
W4413309813
Cited by
75
References
121
Citations by year
2026: 71 · 2025: 4
FWCI
6.01
Type
journal article
Language
en
Open access
Locations
  • Gels (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Era-Min Cofund 2023 (MCIU/AEI/10.13039/501,100,011,033/UE)
Topics
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Materials Science › Biomaterials › Hydrogels: synthesis, properties, applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
Keywords
3D bioprinting, rheology, printability, cell viability, cell proliferation, tissue maturation, vascularization, shape fidelity, structural integrity, regenerative medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rheological, Structural, and Biological Trade-Offs in Bioink Design for 3D Bioprinting. https://app.cochat.ai/papers/10.3390/gels11080659
The paper
Elango, J., & Zamora-Ledezma, C. (2025). Rheological, Structural, and Biological Trade-Offs in Bioink Design for 3D Bioprinting. Gels. https://doi.org/10.3390/gels11080659

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.